Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Hepatology

• Publication date

  1998-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.510270631PMID 9620344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Putting a hold on "HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System.

  1997cited by this paper
• The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression*

  1997cited by this paper
• Putting a hold on ‘HLA–H’

  1997cited by this paper
• Putting a hold on ‘HLA–H’

  1997cited by this paper
• Long‐term consequence of rat orthotopic liver transplantation with and without hepatic arterial reconstruction: A clinical, pathological, and hemodynamic study

  1997cited by this paper
• The frequency of hemochromatosis‐associated alleles is increased in British patients with sporadic porphyria cutanea tarda

  1997cited by this paper
• Increased hepatic iron stores in non alcoholic steatohepatitis (NASH) are associated with the Cys282Tyr hemochromatosis mutation and increased hepatic fibrosis

  1997cited by this paper
• Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations.

  1997cited by this paper
• Hemosiderosis in cirrhosis: a study of 447 native livers.

  1997cited by this paper
• Iron and chronic viral hepatitis

  1997cited by this paper
• Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.

  1997cited by this paper
• A simple genetic test identifies 90% of UK patients with haemochromatosis

  1997cited by this paper
• Haemochromatosis and HLA–H

  1996cited by this paper
• Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

  1996cited by this paper
• Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.

  1996cited by this paper
• Haemochromatosis and HLA–H

  1996cited by this paper
• An update on iron metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism

  1996cited by this paper
• Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

  1996cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Liver iron concentration in chronic viral hepatitis: a study of 98 patients

  1995cited by this paper
• Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis.

  1995cited by this paper
• Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C.

  1995cited by this paper
• Hepatic lipid peroxidation in chronic hepatitis C

  1995cited by this paper
• Reduction of liver iron content following tratment of chronic hepatitis C

  1995cited by this paper
• Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Experimental liver cirrhosis induced by alcohol and iron.

  1995cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• The effect of iron overload on rat plasma and liver oxidant status in vivo.

  1994cited by this paper
• Response to interferon alpha therapy is influenced by the iron content of the liver.

  1994cited by this paper
• Body iron stores and risk of cancer

  1994cited by this paper
• Iron reduction therapy: simply camouflage, or a real weapon?

  1994cited by this paper
• Response to interferon α therapy is influenced by the iron content of the liver

  1994cited by this paper
• Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.

  1993cited by this paper
• Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon-$alpha;

  1993cited by this paper
• Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection.

  1992cited by this paper
• Measurements of iron status in patients with chronic hepatitis.

  1992cited by this paper
• Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients.

  1992cited by this paper
• Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

  1991cited by this paper
• Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients.

  1991cited by this paper
• The critical role of iron in some clinical infections

  1991cited by this paper
• Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index

  1990cited by this paper
• Body iron stores and the risk of cancer.

  1988cited by this paper
• Lipid peroxidation and associated hepatic organelle dysfunction in iron overload.

  1987cited by this paper
• Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis

  1986cited by this paper
• Pathogenesis of hepatic fibrosis in experimental iron overload

  1985cited by this paper
• Iron withholding: a defense against infection and neoplasia.

  1984cited by this paper
• Serum ferritin as a predictor of host response to hepatitis B virus infection.

  1983cited by this paper
• Changes in serum iron levels due to infection with hepatitis B virus.

  1981cited by this paper
• Diseases of the liver

  1975cited by this paper
• Iron-storage disease.

  1956cited by this paper
• Iron storage disease.

  1955cited by this paper
• On Diseases of the Liver

  1903cited by this paper

• Iron Metabolism Genes Shape the Course of Liver Fibrosis in Chronic Hepatitis C: From Disease Progression to Reversal After Direct-Acting Antivirals Treatment

  2025cites this paper
• Current Pharmacotherapy Trends for Hepatitis C in the Hospitals of Faisalabad, Pakistan

  2023cites this paper
• Iron as a therapeutic target in chronic liver disease

  2023cites this paper
• Relationships between serum iron and liver diseases in nutrition intervention trials: A nested case-control study.

  2022cites this paper
• Hepatitis C virus: A critical approach to who really needs treatment

  2022cites this paper
• Noninvasive Biomarkers for Liver Fibrosis

  2020cites this paper
• The role of iron in viral infections.

  2020cites this paper
• Comprehensive analysis of HFE gene in hereditary hemochromatosis and in diseases associated with acquired iron overload

  2019cites this paper
• “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism

  2019cites this paper
• Dietary and Sentinel Factors Leading to Hemochromatosis

  2019cites this paper
• Review article: iron disturbances in chronic liver diseases other than haemochromatosis – pathogenic, prognostic, and therapeutic implications

  2019cites this paper
• Genetik metabolischer und viraler Lebererkrankungen

  2017cites this paper
• Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution

  2017cites this paper
• Natural history of chronic hepatitis C development and progression as a consequence of iron and HFE or TfR1 mutations

  2017cites this paper
• Testing for A Loss of Homozygosity and Compound Heterozygosity Using Human Standing Variation

  2017cites this paper
• Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study

  2016influential citation
• Hemochromatosis gene mutations in chronic hepatitis “C” patients

  2016influential citation
• Serum or plasma ferritin concentration as an index of iron deficiency and overload.

  2015cites this paper
• Predictive Role of Acute Phase Reactants in the Response to Therapy in Patients with Chronic Hepatitis C Virus Infection

  2012cites this paper
• Porfiria cutânea tardia com mutações do gene da hemocromatose C282Y e H63D e análise retrospectiva do perfil de ferro em relação ao tratamento: estudo de 60 casos

  2012cites this paper
• Iron and Liver Disease

  2012cites this paper
• Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C

  2012cites this paper
• Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C

  2012cites this paper
• Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

  2012cites this paper
• New insights into hepatitis

  2012cites this paper
• Iron Overload and HFE Gene Mutations in Czech Patients with Chronic Liver Diseases

  2012cites this paper
• Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin.

  2012cites this paper
• Iron metabolic disorder in chronic hepatitis C: insights from recent evidence

  2012cites this paper
• Pathogenesis and clinical consequences of iron overload in chronic hepatitis C -- impact of host and viral factors related to iron metabolism

  2011cites this paper
• CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Iron Levels in Hepatocytes and Portal Tract Cells Predict Progression and Outcomes of Patients With Advanced Chronic Hepatitis C

  2011cites this paper
• Hemochromatosis and Iron Storage Disorders

  2011cites this paper
• Iron in the Liver: A Review for Surgical Pathologists

  2011cites this paper
• Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants

  2011cites this paper
• Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C

  2011cites this paper
• Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.

  2011cites this paper
• Hereditary hemochromatosis of tongue.

  2011cites this paper
• Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients

  2011cites this paper
• Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.

  2011cites this paper
• The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C

  2010cites this paper
• Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.

  2010cites this paper
• The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.

  2010cites this paper
• Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy

  2010cites this paper
• Iron Metabolism and Disease

  2010cites this paper
• Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.

  2009cites this paper
• Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.

  2009cites this paper
• Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.

  2009cites this paper
• Evaluation of standard liver volume formulae for Chinese adults.

  2009cites this paper
• Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.

  2009cites this paper
• Der Einfluss der Hämochromatose (HFE)-Gen-Varianten auf die Progression chronischer Lebererkrankungen und die Entwicklung eines hepatozellulären Karzinoms

  2009cites this paper
• O papel das mutações do gene HFE e da sobrecarga de ferro na evolução da hepatite crônica pelo VHC

  2009cites this paper
• Frequency and influence of hemochromatosis gene mutations in kidney transplant recipients with or without hepatitis C virus infection.

  2009cites this paper
• Combinatorialuseofsingle nucleotidepolymorphismstohelp predictliverfibrosisinpatients withhepatitisCinfections

  2009cites this paper
• The role of iron in the pathophysiology and treatment of chronic hepatitis C.

  2009cites this paper
• Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron.

  2009cites this paper
• TOPIC HIGHLIGHT

  2009cites this paper
• Recognition of Genetic Factors Influencing the Progression of Hepatitis C

  2008cites this paper
• Systematic review: hepatic fibrosis – regression with therapy

  2008cites this paper
• Genetische Assoziationsstudien der immunologisch relevanten Gene CCR5, CX3CR1 und RANTES zur klinischen Risikostratifizierung von Patienten mit chronischer Hepatitis C

  2008cites this paper
• Polymorphismes génétiques associés à une fibrose du foie, leurs procédés de détection et leurs utilisations

  2008cites this paper
• Mit Leberfibrose assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen

  2008cites this paper
• Polymorphismes génétiques associés à la fibrose du foie, procédés de détection et utilisations associées

  2008cites this paper
• Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

  2008cites this paper
• The effect of iron depletion on chronic hepatitis C virus infection

  2008cites this paper
• Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

  2007cites this paper
• Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection

  2007cites this paper
• Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis C

  2007cites this paper
• Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.

  2007cites this paper
• Genomics of liver fibrosis and cirrhosis.

  2007cites this paper
• Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection

  2007cites this paper
• Analysis of hepatitis C virus-specific CD8+ T-cells with HLA-A*24 tetramers during phlebotomy and interferon therapy for chronic hepatitis C.

  2007cites this paper
• An Unusual Case of Hemochromatosis in an African-American Man: Case Report and Review of the Literature

  2007cites this paper
• Iron chelation beyond transfusion iron overload

  2007cites this paper
• HFE gene in primary and secondary hepatic iron overload.

  2007cites this paper
• Estudo das mutações C282Y, H63D e S65C do gene HFE em doentes brasileiros com sobrecarga de ferro Study of C282Y, H63D and S65C mutations in the HFE gene in Brazilian patients with iron overload

  2007cites this paper
• HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech population

  2007cites this paper
• Genetics, Genomics, and Proteomics: Implications for the Diagnosis and the Treatment of Chronic Hepatitis C

  2007cites this paper
• HFE genotypes in patients with chronic pancreatitis and pancreatic adenocarcinoma

  2007cites this paper
• Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality

  2007cites this paper
• Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1

  2007cites this paper
• Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

  2007cites this paper
• Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis

  2007cites this paper
• Genomics of Liver Fibrosis and Cirrhosis

  2007cites this paper
• Recommandations pour la pratique clinique

  2006cites this paper
• Progression of hepatic fibrosis in chronic hepatitis C and the need for treatment in mild disease.

  2006cites this paper
• Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?

  2006cites this paper
• CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C

  2006cites this paper
• Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C

  2006cites this paper
• Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.

  2006cites this paper
• Iron, HCV, and liver cancer: hard metal setting the pace?

  2006cites this paper
• Chronic Hepatitis C Treatment Patterns in African American Patients: An Update

  2005cites this paper
• The liver biopsy in chronic hepatitis C: a view from the other side of the microscope.

  2005cites this paper
• Genetic studies to identify hepatic fibrosis genes and SNPs in human populations.

  2005cites this paper
• Review article: chronic hepatitis C – natural history and cofactors

  2005cites this paper
• [Factors associated with the severity of liver damage in chronic hepatitis C].

  2005cites this paper
• Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan

  2005cites this paper
• Hemochromatosis mutations in Iranians with hepatitis B virus infection.

  2005cites this paper
• Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.

  2005cites this paper
• Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.

  2005cites this paper
• HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.

  2005cites this paper
• Iron in nonhemochromatotic liver disorders.

  2005cites this paper